Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/IJGM.S74880 http://scihub22266oqcxt.onion/10.2147/IJGM.S74880 C4590408!4590408!26451121     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Int+J+Gen+Med 2015 ; 8 (ä): 309-18 Nephropedia Template TP {{tp|p=26451121|t=2015. Managing comorbidities in idiopathic pulmonary fibrosis |pdf=|usr=}}{{26451121}} gab.com Text Managing comorbidities in idiopathic pulmonary fibrosis JO: Int J Gen Med http://www.kidney.de/pget.php?&tw=1&pmid=26451121 #FOAvip Major risk factors for idiopathic pulmonary fibrosis (IPF) include older age and a history of smoking, which predispose to several pulmonary and extra-pulmonary diseases. IPF can be associated with additional comorbidities through other mechanisms as either a cause or a consequence of these diseases. We review the literature regarding the management of common pulmonary and extra-pulmonary comorbidities, including chronic obstructive pulmonary disease, lung cancer, pulmonary hypertension, venous thromboembolism, sleep-disordered breathing, gastroesophageal reflux disease, coronary artery disease, depression and anxiety, and deconditioning. Recent studies have provided some guidance on the management of these diseases in IPF; however, most treatment recommendations are extrapolated from studies of non-IPF patients. Additional studies are required to more accurately determine the clinical features of these comorbidities in patients with IPF and to evaluate conventional treatments and management strategies that are beneficial in non-IPF populations. Twit Text FOAVip Managing comorbidities in idiopathic pulmonary fibrosis ????Int J Gen Med http://www.kidney.de/pget.php?&tw=1&pmid=26451121 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26451121 #FOAvip English Wikipedia <ref>{{Cite pmid|26451121}}</ref> Managing comorbidities in idiopathic pulmonary fibrosis #MMPMID26451121 Fulton BG; Ryerson CJ Int J Gen Med 2015[]; 8 (ä): 309-18 PMID26451121show ga Major risk factors for idiopathic pulmonary fibrosis (IPF) include older age and a history of smoking, which predispose to several pulmonary and extra-pulmonary diseases. IPF can be associated with additional comorbidities through other mechanisms as either a cause or a consequence of these diseases. We review the literature regarding the management of common pulmonary and extra-pulmonary comorbidities, including chronic obstructive pulmonary disease, lung cancer, pulmonary hypertension, venous thromboembolism, sleep-disordered breathing, gastroesophageal reflux disease, coronary artery disease, depression and anxiety, and deconditioning. Recent studies have provided some guidance on the management of these diseases in IPF; however, most treatment recommendations are extrapolated from studies of non-IPF patients. Additional studies are required to more accurately determine the clinical features of these comorbidities in patients with IPF and to evaluate conventional treatments and management strategies that are beneficial in non-IPF populations. äManaging comorbidities in idiopathic pulmonary fibrosis (epmc).pdf DeepDyve Pubget Overpricing